One-Year Results of First-Line Treatment Strategies in Patients With Critical Limb Ischemia (CRITISCH Registry)
Authors: Stavroulakis Konstantinos , Borowski Matthias , Torsello Giovanni , Bisdas Theodosios , Adili Farzin , Balzer Kai , Billing Arend , Böckler Dittmar , Brixner Daniel , Debus E. Sebastian , Eckstein Hans-Henning , Florek Hans-Joachim , Gkremoutis Asimakis , Grundmann Reinhardt , Hupp Thomas , Keck Tobias , Gerß Joachim , Wojciech Klonek , Lang Werner , May Björn , Meyer Alexander , Mühling Bernhard , Oberhuber Alexander , Reinecke Holger , Reinhold Christian , Ritter Ralf-Gerhard , Schelzig Hubert , Schlensack Christian , Schmitz-Rixen Thomas , Schulte Karl-Ludwig , Spohn Matthias , Steinbauer Markus , Storck Martin , Trede Matthias , Uhl Christian , Weis-Müller Barbara , Wenk Heiner , Zeller Thomas , Zhorzel Sven , Zimmermann Alexander 
Published: April 2018

Purpose: To examine the outcomes of all first-line strategies for the treatment of critical limb ischemia (CLI), identify factors that influenced the treatment choice, and determine the risk of amputation or death after each treatment. Methods: CRITISCH ( ClinicalTrials.gov identifier NCT01877252) is a multicenter, national, prospective registry evaluating all available treatment strategies applied in 1200 consecutive CLI patients in 27 vascular centers in Germany. The recruitment started in January 2013 and was completed in September 2014. Treatment options were endovascular revascularization (642, 53.5%), bypass surgery (284, 23.7%), femoral artery patchplasty (126, 10.5%) with or without concomitant peripheral intervention, conservative treatment (118, 9.8%), and primary major amputation (30, 2.5%). The primary endpoint of this study was amputation-free survival (AFS). The Society of Vascular Surgery’s suggested objective performance goal (OPG) for AFS (71%) was used as the effectiveness criterion. Multivariable regression methods were employed to identify variables that influenced the treatment selection and AFS after each treatment; results are presented as the hazard ratio (HR) and 95% confidence interval (CI). Results: The 12-month AFS estimates following endovascular therapy, bypass grafting, femoral patchplasty, and conservative treatment were 75%, 72%, 73%, and 72%, respectively. Factors influencing treatment choice were age, chronic kidney disease (CKD), diabetes, smoking, prior vascular procedures in the index leg, TransAtlantic Inter-Society Consensus II C/D lesions, and absence of runoff vessels. Cox regression analysis identified CKD (HR 2.07, 95% CI 1.26 to 3.41, p=0.004), the use of a prosthetic bypass conduit (HR 1.97, 95% CI 1.23 to 3.14, p=0.004), and previous vascular intervention in the index limb (HR 1.52, 95% CI 0.94 to 2.43, p=0.085) as independent risk factors for diminished AFS after bypass surgery. CKD (HR 1.47, 95% CI 1.09 to 1.99, p=0.012) and Rutherford category 6 (HR 1.81, 95% CI 1.30 to 2.52, p<0.001) compromised the performance of endovascular revascularization. Conclusion: CRITISCH registry data revealed that all first-line treatment strategies selected and indicated by the treating physicians met the suggested OPGs. CKD was an important determinant of patient prognosis after treatment regardless of the revascularization method.